Ralph del Campo
2008
In 2008, Ralph del Campo earned a total compensation of $1.3M as Chief Operating Officer and Principal Executive Officer at Enzon Pharmaceuticals, a 6% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $320,000 |
---|---|
Salary | $412,263 |
Stock Awards | $512,600 |
Other | $33,184 |
Total | $1,278,046 |
del Campo received $512.6K in stock awards, accounting for 40% of the total pay in 2008.
del Campo also received $320K in non-equity incentive plan, $412.3K in salary and $33.2K in other compensation.
Rankings
In 2008, Ralph del Campo's compensation ranked 3,647th out of 9,135 executives tracked by ExecPay. In other words, del Campo earned more than 60.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,647 | 60th |
Manufacturing | 1,307 | 62nd |
Chemicals And Allied Products | 243 | 70th |
Drugs | 140 | 77th |
Biological Products, Except Diagnostic Substances | 24 | 80th |
del Campo's colleagues
We found five more compensation records of executives who worked with Ralph del Campo at Enzon Pharmaceuticals in 2008.
2008
Jeffrey Buchalter
Enzon Pharmaceuticals
Chief Executive Officer
2008
Craig Tooman
Enzon Pharmaceuticals
Chief Financial Officer
2008
Ivan Horak
Enzon Pharmaceuticals
Chief Scientific Officer
2008
Paul Davit
Enzon Pharmaceuticals
Executive Vice President, Human Resources and Administration
2008
Mark Ogden
Enzon Pharmaceuticals